Literature DB >> 30756076

Safety of Thrombolysis in a Patient with an Intracranial Dural Arteriovenous Fistula.

Ana João Pissarra1, Mariana Malheiro1, Carolina Gouveia2, Patrícia Vicente2, Leonor Matos1.   

Abstract

Intracranial dural arteriovenous fistula is an abnormal connection between an artery and a vein that has an increased risk of bleeding. This case report presents a 53-year-old man diagnosed with a dural arteriovenous malformation fistula in occipital topography, lacking therapeutic indication because of an extension. He was admitted to an intensive care unit due to a high-risk pulmonary thromboembolism with indication for thrombolysis. Taking into account the hemorrhagic risk associated with arteriovenous malformation, the authors discuss the therapeutic options and the inherent risks. LEARNING POINTS: Intracranial dural arteriovenous fistulas are pathologic shunts between dural arteries and veins that have an inherent risk of intracranial hemorrhage.Systemic thrombolytic agents are a therapeutic option for high-risk pulmonary thromboembolism. Their potential benefits outweigh the risk of life-threatening bleeding; however, careful patient risk stratification should be performed and other options, such as surgical embolectomy or percutaneous catheter-directed treatment, should be considered if available.Multidisciplinarity is the key to better therapeutic decisions and the patient's opinion should always be taken into account.

Entities:  

Keywords:  Pulmonary thromboembolism; arteriovenous malformation; thrombolysis

Year:  2019        PMID: 30756076      PMCID: PMC6372050          DOI: 10.12890/2019_001019

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  7 in total

Review 1.  Intracranial dural arteriovenous fistulas: classification, imaging findings, and treatment.

Authors:  D Gandhi; J Chen; M Pearl; J Huang; J J Gemmete; S Kathuria
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

2.  Comparison of alteplase versus heparin for resolution of major pulmonary embolism.

Authors:  S Konstantinides; N Tiede; A Geibel; M Olschewski; H Just; W Kasper
Journal:  Am J Cardiol       Date:  1998-10-15       Impact factor: 2.778

3.  2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism.

Authors:  Stavros V Konstantinides; Adam Torbicki; Giancarlo Agnelli; Nicolas Danchin; David Fitzmaurice; Nazzareno Galiè; J Simon R Gibbs; Menno V Huisman; Marc Humbert; Nils Kucher; Irene Lang; Mareike Lankeit; John Lekakis; Christoph Maack; Eckhard Mayer; Nicolas Meneveau; Arnaud Perrier; Piotr Pruszczyk; Lars H Rasmussen; Thomas H Schindler; Pavel Svitil; Anton Vonk Noordegraaf; Jose Luis Zamorano; Maurizio Zompatori
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

Review 4.  Alteplase treatment of acute pulmonary embolism in the intensive care unit.

Authors:  Pamela L Smithburger; Shauna Campbell; Sandra L Kane-Gill
Journal:  Crit Care Nurse       Date:  2013-04       Impact factor: 1.708

5.  Systemic Thrombolysis for Pulmonary Embolism: A Review.

Authors:  Colleen Martin; Kristine Sobolewski; Patrick Bridgeman; Daniel Boutsikaris
Journal:  P T       Date:  2016-12

6.  Natural history of dural arteriovenous shunts.

Authors:  Michael Söderman; Ladislav Pavic; Göran Edner; Staffan Holmin; Tommy Andersson
Journal:  Stroke       Date:  2008-04-03       Impact factor: 7.914

Review 7.  Intracranial hemorrhage from dural arteriovenous fistulas: clinical features and outcome.

Authors:  David J Daniels; Ananth K Vellimana; Gregory J Zipfel; Giuseppe Lanzino
Journal:  Neurosurg Focus       Date:  2013-05       Impact factor: 4.047

  7 in total
  1 in total

1.  Effects of Arteriovenous Thrombolysis Combined with Mechanical Thrombectomy on Efficacy and Neurological Function of Acute Cerebral Infarct Patients.

Authors:  Tao Ding; Liwen Tang; Bohong Hu; Junxin Yuan; Xiangdong Li; Jun Wen
Journal:  Biomed Res Int       Date:  2020-10-09       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.